全文获取类型
| 收费全文 | 1276276篇 |
| 免费 | 94330篇 |
| 国内免费 | 1989篇 |
专业分类
| 耳鼻咽喉 | 18198篇 |
| 儿科学 | 42297篇 |
| 妇产科学 | 37889篇 |
| 基础医学 | 187234篇 |
| 口腔科学 | 35384篇 |
| 临床医学 | 108171篇 |
| 内科学 | 251500篇 |
| 皮肤病学 | 26502篇 |
| 神经病学 | 99458篇 |
| 特种医学 | 50047篇 |
| 外国民族医学 | 366篇 |
| 外科学 | 197779篇 |
| 综合类 | 26519篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 300篇 |
| 预防医学 | 92633篇 |
| 眼科学 | 29041篇 |
| 药学 | 97885篇 |
| 1篇 | |
| 中国医学 | 2496篇 |
| 肿瘤学 | 68894篇 |
出版年
| 2018年 | 11865篇 |
| 2015年 | 11657篇 |
| 2014年 | 16049篇 |
| 2013年 | 24437篇 |
| 2012年 | 33665篇 |
| 2011年 | 36095篇 |
| 2010年 | 21298篇 |
| 2009年 | 20080篇 |
| 2008年 | 35062篇 |
| 2007年 | 38058篇 |
| 2006年 | 38595篇 |
| 2005年 | 37890篇 |
| 2004年 | 36482篇 |
| 2003年 | 35432篇 |
| 2002年 | 34994篇 |
| 2001年 | 58125篇 |
| 2000年 | 59600篇 |
| 1999年 | 50710篇 |
| 1998年 | 14242篇 |
| 1997年 | 12823篇 |
| 1996年 | 13081篇 |
| 1995年 | 12350篇 |
| 1994年 | 11764篇 |
| 1993年 | 10866篇 |
| 1992年 | 41000篇 |
| 1991年 | 40381篇 |
| 1990年 | 39904篇 |
| 1989年 | 38722篇 |
| 1988年 | 36122篇 |
| 1987年 | 35367篇 |
| 1986年 | 33740篇 |
| 1985年 | 32157篇 |
| 1984年 | 23939篇 |
| 1983年 | 20827篇 |
| 1982年 | 12381篇 |
| 1981年 | 10935篇 |
| 1980年 | 10209篇 |
| 1979年 | 22653篇 |
| 1978年 | 15886篇 |
| 1977年 | 13734篇 |
| 1976年 | 12982篇 |
| 1975年 | 14208篇 |
| 1974年 | 16694篇 |
| 1973年 | 16083篇 |
| 1972年 | 15323篇 |
| 1971年 | 14234篇 |
| 1970年 | 13222篇 |
| 1969年 | 12735篇 |
| 1968年 | 11980篇 |
| 1967年 | 10480篇 |
排序方式： 共有10000条查询结果，搜索用时 562 毫秒
151.
152.
Health care expenditure in Germany shows clear regional differences. Such geographic variations are often seen as an indicator for inefficiency. With its homogeneous health care system, low co‐payments and uniform prices, Germany is a particularly suited example to analyse regional variations. We use data for the year 2011 on expenditure, utilization of health services and state of health in Germany's statutory health insurance system. This data, which originate from a variety of administrative sources and cover about 90% of the population, are enriched with a wealth of socio‐economic variables, data on pollutants, prices and individual preferences. State of health and demography explains 55% of the differences as measured by the standard deviation while all control variables account for a total of 72% of the differences at county level. With other measures of variation, we can account for an even greater proportion. A higher proportion of variation than usually supposed can thus be explained. Whilst this study cannot quantify inefficiencies, our results contradict the thesis that regional variations reflect inefficiency. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
153.
154.
155.
156.
157.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献158.
Cécile Vicier Lillian Werner Jonathan Chipman Lauren C. Harshman Dattatraya H. Patil Raina N. Fichorova Jennifer R. Rider Martin G. Sanda Lorelei A. Mucci Christopher J. Sweeney 《Clinical genitourinary cancer》2019,17(1):32-37
Background
Inflammation and infections have been associated with prostate cancer progression. We assessed whether elevated serum cytokines or T. vaginalis seropositivity at the time of diagnosis was associated with higher grade or lethal prostate cancer.Patients and Methods
Men with localized or metastatic prostate cancer were included in this study. Cytokine serum levels including interleukin (IL)-1α, IL-1β, IL-2, IL-6, IL-8, monocyte chemotactic protein 1 (CCL-2), tumor necrosis factor α, and growth-regulated oncogene α (CXCL-1) using a multiplex enzyme-linked immunosorbent assay and T. vaginalis serology were measured in blood samples at diagnosis.Results
A total of 324 patients were identified at time of localized disease and 118 at time of metastatic disease. Of the 189 patients with localized disease and clinical follow-up data (median, 73 months), 28 developed lethal disease. There was no association between circulating cytokine levels above median concentrations nor T. vaginalis seropositivity and risk of intermediate- to high-risk or lethal prostate cancer.Conclusion
Higher levels of serum cytokine levels and T. vaginalis seropositivity at diagnosis are not associated with high-grade or lethal prostate cancer and do not aid risk stratification of localized prostate cancer. 相似文献159.
160.